X-72579737-T-TAC

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBA1

The NM_002637.4(PHKA1):​c.*1263_*1264dupGT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.078 ( 801 hom., 1815 hem., cov: 19)
Exomes 𝑓: 0.0 ( 0 hom. 0 hem. )
Failed GnomAD Quality Control

Consequence

PHKA1
NM_002637.4 3_prime_UTR

Scores

Not classified

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 1.62

Publications

0 publications found
Variant links:
Genes affected
PHKA1 (HGNC:8925): (phosphorylase kinase regulatory subunit alpha 1) Phosphorylase kinase is a polymer of 16 subunits, four each of alpha, beta, gamma and delta. The alpha subunit includes the skeletal muscle and hepatic isoforms, and the skeletal muscle isoform is encoded by this gene. The beta subunit is the same in both the muscle and hepatic isoforms, and encoded by one gene. The gamma subunit also includes the skeletal muscle and hepatic isoforms, which are encoded by two different genes. The delta subunit is a calmodulin and can be encoded by three different genes. The gamma subunits contain the active site of the enzyme, whereas the alpha and beta subunits have regulatory functions controlled by phosphorylation. The delta subunit mediates the dependence of the enzyme on calcium concentration. Mutations in this gene cause glycogen storage disease type 9D, also known as X-linked muscle glycogenosis. Alternatively spliced transcript variants encoding different isoforms have been identified in this gene. A pseudogene has been found on chromosome 1.[provided by RefSeq, Feb 2010]
PHKA1 Gene-Disease associations (from GenCC):
  • glycogen storage disease IXd
    Inheritance: XL, AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP6
Variant X-72579737-T-TAC is Benign according to our data. Variant chrX-72579737-T-TAC is described in ClinVar as [Benign]. Clinvar id is 368633.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.254 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PHKA1NM_002637.4 linkc.*1263_*1264dupGT 3_prime_UTR_variant Exon 32 of 32 ENST00000373542.9 NP_002628.2 P46020-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PHKA1ENST00000373542.9 linkc.*1263_*1264dupGT 3_prime_UTR_variant Exon 32 of 32 1 NM_002637.4 ENSP00000362643.4 P46020-1
PHKA1ENST00000339490.7 linkc.*1263_*1264dupGT 3_prime_UTR_variant Exon 31 of 31 1 ENSP00000342469.3 P46020-2
PHKA1ENST00000541944.5 linkc.*1263_*1264dupGT 3_prime_UTR_variant Exon 30 of 30 1 ENSP00000441251.1 P46020-3
PHKA1ENST00000373545.7 linkc.*1263_*1264dupGT 3_prime_UTR_variant Exon 32 of 32 5 ENSP00000362646.3 A6NIT2

Frequencies

GnomAD3 genomes
AF:
0.0775
AC:
8222
AN:
106146
Hom.:
802
Cov.:
19
show subpopulations
Gnomad AFR
AF:
0.259
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0351
Gnomad ASJ
AF:
0.000789
Gnomad EAS
AF:
0.00691
Gnomad SAS
AF:
0.0130
Gnomad FIN
AF:
0.000951
Gnomad MID
AF:
0.0388
Gnomad NFE
AF:
0.00406
Gnomad OTH
AF:
0.0618
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
34
Hom.:
0
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
20
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
31
Other (OTH)
AF:
0.00
AC:
0
AN:
3
GnomAD4 genome
AF:
0.0776
AC:
8236
AN:
106163
Hom.:
801
Cov.:
19
AF XY:
0.0603
AC XY:
1815
AN XY:
30101
show subpopulations
African (AFR)
AF:
0.259
AC:
7523
AN:
29036
American (AMR)
AF:
0.0351
AC:
345
AN:
9835
Ashkenazi Jewish (ASJ)
AF:
0.000789
AC:
2
AN:
2534
East Asian (EAS)
AF:
0.00664
AC:
23
AN:
3462
South Asian (SAS)
AF:
0.0135
AC:
33
AN:
2450
European-Finnish (FIN)
AF:
0.000951
AC:
5
AN:
5259
Middle Eastern (MID)
AF:
0.0423
AC:
9
AN:
213
European-Non Finnish (NFE)
AF:
0.00406
AC:
208
AN:
51268
Other (OTH)
AF:
0.0612
AC:
88
AN:
1439
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
234
467
701
934
1168
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
84
168
252
336
420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000349
Hom.:
7

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Glycogen phosphorylase kinase deficiency Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs111688568; hg19: chrX-71799587; API